Eli Lilly VS Mochi Update from the Courtroom!

Eli Lilly VS Mochi Update from the Courtroom!

Original posted at obesity.news/ on Aug 30, 2025

Today was a big day for our community. My friend Sabina, co-founder of GLPwinner.com, went inside the federal courthouse in San Francisco for the Eli Lilly vs Mochi Health hearing. Thanks to her efforts, we have the first patient-centered account of what actually went down. Without Sabina’s presence in the courtroom, we’d still be in the dark. I was honored to host her on On The Pen to spend some time chatting about not only what was discussed in the courtroom, but what this actually means for patients and the future of accessiblity to treatment. This is a topic that I know Sabina genuinely cares about deeply, and this conversation was a real treat… Enjoy:

https://www.youtube.com/watch?v=sDzvyzpLV98

Paid Subscribers are the lifeblood of OTP. While

hate to ask for anything of you, we simply

cannot do what we do without you. Your

support means everything to our efforts.

Subscribe

Sabina’s take on the hearing? “Embarassing” for Eli Lilly.

According to Sabina’s account, for nearly the entire 2 hour plus session, Judge Corley grilled Lilly’s counsel. Over and over she pressed them to produce concrete evidence and direct harms. The Judge Corley wasn’t satisfied with vague claims or hypotheticals. Screenshots of Reddit posts were about the strongest argument Lilly put forth, and that did not fly. She wanted facts, and Lilly simply did not deliver.

At one point she even said to Lilly’s lawyers: “What I hear you saying is that you don’t have anything.”

She challenged them on Article III standing, going claim by claim, asking what specific injury Lilly had suffered. At one point, she even told Lilly’s counsel if they didn’t like Mochi selling compounded medication, they should “go talk to the FDA and Congress.”

Judge Corley went on to question whether compounded patients were even Lilly’s customers to begin with. The judge contended that said patients likely couldn’t afford Lilly’s drugs, and without Mochi, they might have turned to other options altogether. When pressed on the actual price of Zepbound, Lilly’s counsel couldn’t provide the court with a clear answer.

According to Sabina’s account here are the main points that did not pass muster in the eye of Judge Corley:

• Claims about Myra Ahmad allegedly presenting herself as a practicing medical doctor.

• Arguments around Mochi shifting from Aequita pharmacy to others

• Mochi marketing that referenced SURMOUNT trial results. The judge noted that in her estimation tirzepatide is tirzepatide.

• Assertions that compounded versions are unsafe or ineffective, the burden of proof, she said, is on Lilly (which they were unable to substantiate).

• The lack of specifics surrounding Aequita Pharmacy’s shutting down by the WA State Pharmacy Board.

• Using Reddit as evidence without any meaningful follow up

We owe Sabina a debt of gratitude for this ground-level look at a fight that could shape the future of patient access. Please make sure to follow Sabina

on all the social feeds at @Lawliepop and @Lawliepops on instagram!